Prescription Monitoring Program
|
**Update** Public Act 21-182. Effective June 28, 2021, veterinarians, licensed under chapter 384, are exempt from the reporting requirement for the dispensation of insulin drugs, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices for animal patients. Public Act 21-192. Effective July 1, 2022, federal Substance Abuse and Mental Health Services Administration certified substance use disorder clinics licensed under section 19a-495 in accordance with 42 CFR 2 will be mandated to report prescription information for dispensed schedules II, III, IV and V controlled substances to the prescription drug monitoring program.
Effective January 1, 2021, dispensation information for insulin drugs, glucagon drugs, diabetes devices, diabetic ketoacidosis devices, gabapentin, and naloxone are required to be uploaded into the CPMRS. All listed prescriptions will be available on patient reports except for naloxone. Only CPMRS admin will have access to naloxone data for the purpose of aggregate population analytics that will help to inform public policy. For more information, please visit the For Pharmacists webpage.
**Update** NO-COST* CPMRS Integration. Streamline your workflow. Save Time. Focus on Patient Care. The CPMRS can
now be accessed through approved electronic health records (EHR) and pharmacy
management systems (PMS) where PDMP data and NarxCare analytics will be
delivered directly into your workflow. The Connecticut Prescription Monitoring
Program (PMP) is pleased to announce a statewide initiative to integrate the
CPMRS into approved EHR/PMS using Appriss Health’s PMP Gateway service.
For more
information, navigate to CPMRS Integration to take advantage of the opportunity.
For a limited of time, the *initial set-up fee and *user fees will be waived due
to funding from the Centers for Medicare & Medicaid Services (CMS) of the
U.S. Department of Health and Human Services (HHS).
The Prescription Monitoring Program collects prescription data for Schedule II through Schedule V drugs into a centralized database, the Connecticut Prescription Monitoring and Reporting System (CPMRS), which can then be used by healthcare providers and pharmacists in the active treatment of their patients. The purpose of the CPMRS is to present a complete picture of a patient’s controlled substance use, including prescriptions by other providers. As a healthcare tool, the CPMRS is used to improve quality of patient care and to reduce prescription abuse, addiction, and overdose. This allows providers the opportunity to properly manage the patient’s treatment, including referral of a patient to services offering treatment for drug abuse or addiction when appropriate. |
|
|
Under Connecticut law, information about all transactions for Schedule II-V controlled substances dispensed in Connecticut must be reported to the CPMRS. Pharmacies - both in and out of state - and dispensing practitioners must submit data daily. Please Note: Dispensing pharmacies and medical marijuana dispensaries upload prescription data daily, and prescribing veterinarians upload at least once per week. All CPMRS data should be verified with the prescribing practitioner and/or pharmacist. |
|
Interstate Data Sharing. Authorized roles in the CPMRS currently have access to prescription data from 39 states, Washington DC, Puerto Rico, and the Military Health System. This includes all border states. Connecticut allow other states to connect via the PMP Interconnect (PMPi) or RxCheck, which are data sharing hubs that use end-to-end encryption to facilitate data sharing across state borders.
- Prescription Drop Box Application and Sample Brochures
- Brochure: Medication Drop-Box Program
- Towns with Prescription Drop Boxes
For more information regarding our prescriber and pharmacist educational campaign, please visit our CHANGE the SCRxIPT webpage.
